Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations
- PMID: 1685600
- DOI: 10.1002/syn.890090309
Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations
Abstract
Treatment with efficacious antipsychotic drugs such as haloperidol increases the concentrations of neurotensin (NT) in the nucleus accumbens and caudate nucleus of the rat. These increases in NT concentrations may be associated with the therapeutic and/or side effects of these drugs. CI-943, a novel compound without appreciable affinity for dopamine-binding sites, produces behavioral effects in animals, which suggest that it may possess antipsychotic activity. This study evaluated the effects of subchronic treatment (3 weeks) with CI-943 or haloperidol on regional brain NT concentrations in rats. Haloperidol treatment (1 mg/kg) produced significant increases in the concentrations of NT in the nucleus accumbens and caudate nucleus but not in the other brain regions studied. Like haloperidol, CI-943 (40 mg/kg) increased NT concentrations in the nucleus accumbens and caudate but differed in that CI-943 produced significantly greater increases in NT concentration in the caudate than haloperidol and also increased NT content in the substantia nigra/ventral tegmental area and hypothalamus. The regional specificity of the NT alterations produced by chronic treatment with CI-943, a nondopamine receptor ligand, was similar to that previously reported after treatment with multiple doses of methamphetamine.
Similar articles
-
Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.J Pharmacol Exp Ther. 1992 Jul;262(1):348-55. J Pharmacol Exp Ther. 1992. PMID: 1625208
-
Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.J Pharmacol Exp Ther. 2000 Oct;295(1):67-73. J Pharmacol Exp Ther. 2000. PMID: 10991962
-
Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.J Pharmacol Exp Ther. 1990 Jul;254(1):330-5. J Pharmacol Exp Ther. 1990. PMID: 1973198
-
The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.J Clin Psychiatry. 1994 Sep;55 Suppl B:30-2. J Clin Psychiatry. 1994. PMID: 7961568 Review.
-
Antipsychotics and neuropeptides: the atypical profile of CI-943 and its relationship to neurotensin.Neurosci Biobehav Rev. 1995 Winter;19(4):519-31. doi: 10.1016/0149-7634(95)00016-x. Neurosci Biobehav Rev. 1995. PMID: 8684714 Review.
Cited by
-
Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonist.J Comput Aided Mol Des. 1994 Aug;8(4):433-40. doi: 10.1007/BF00125377. J Comput Aided Mol Des. 1994. PMID: 7815094
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials